IIN — Stock Film
STOCK FILMSCENE 1/11IIN · $24.23
Stock Expert AI presents
IIN
IntriCon Corporation
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
IntriCon Corporation. What it actually does.

Designs and manufactures micro-miniature products. Provides microelectronics and micro-mechanical assemblies. Now — the numbers.

on the stock market since 1980
873 employees
WHERE DOES THE MONEY COME FROM?
58%Medical Biotelemetry Diabetes
Medical Biotelemetry DiabetesMedical Biotelemetry Other 19%Legacy Oem 9%Hearing Health Value Based Itec 5%Professional Audio Communications 5%Other 4%
58% of all revenue comes from a single line: Medical Biotelemetry Diabetes.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Revenue last year:
$125.2M
The loss that same year:
$64K
Sales don’t cover the costs; the gap drains from the cash pile every year.

The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.

THE SALES TREND
Sales are growing overall, with a pause along the way.

Average growth of 9% a year over the last 4 years. Red columns mark years that ended in a loss.

$88.3M
2017
2018
2019
2020
$125.2M
2021
In the vault right now:
$25M
DEBT: $5.2M
At this pace, that money lasts about 390.7 years.

At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Little set aside for the future2/10
WORTH WATCHING

R&D Investment: Spending on future research is low.

THE FIVE-YEAR JOURNEY
Trading below its recent peak.

The stock trades below its recent peak — about 11% off the top. A pullback, not a collapse.

1
THE BRIGHT SIDE · 1/3
Sales keep climbing

Over the last 4 years, sales grew about 9% a year on average.

2
THE BRIGHT SIDE · 2/3
The product is selling

Sales run at $125.2M a year. A small number, but proof the product has real buyers.

3
THE BRIGHT SIDE · 3/3
Strong cash, light debt

There is $25.0M in the vault; even if every debt were paid off, $19.8M would remain.

1
THE RISKS · 1/3
Small scale, thin loss

A loss of $64K against $125.2M in annual sales.

2
THE RISKS · 2/3
The stock has lost its spark

The price action doesn’t yet back an upward turn. Council score: 0/10.

3
THE RISKS · 3/3
Little set aside for the future

The share set aside for the future is small; the pace of new ideas may slow. Council score: 2/10.

FINALE · THE GRADE
grade pending

We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.

One-line summary: few numbers, an untested story. Keep watching.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Sep 12, 2026 · stockexpertai.com · Stock Film